Skip to content

Clinical trials

Phase 2 Glioblastoma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Status: Unknown status Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20052
20061
20073
20082
20093
20102
20111
20123
20142
20163
20172
20193
20207
20216
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Huashan Hospital2
Adnexus, A Bristol-Myers Squibb R&D Company1
Anders Rosendal Korshøj1
Arno Therapeutics1
Assistance Publique - Hôpitaux de Paris1
Bassam Abdulkarim1
Bradmer Pharmaceuticals Inc.1
CANbridge Life Sciences Ltd.1
China Medical University Hospital1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma47
Brain Neoplasms10
Gliosarcoma9
Glioma6
Central Nervous System Neoplasms5
Astrocytoma4
Recurrence4
Neoplasms2
Oligodendroglioma2
Brain Diseases1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.